|
|
||||||||
Editorials |
Affymetrix, Inc, 3380 Central Expressway, Santa Clara, CA 95051, Fax 408-481-0422, E-mail tom_gingeras@affymetrix.com
| The first 20% of the full text of this article appears below. |
While walking up several flights of stairs in an elevator-deprived building recently, my colleague, between some gasps of breath, turned to me and exclaimed that he had to start his New Years resolution and begin exercising again. At that moment this seemed to me to be a very sensible thought, given his fish-like gasping and chameleon-like color changes. However, I also recalled that my colleague had a history of serious asthma and a travel schedule that rivaled most airline pilots. I asked him how he would be managing these challenges while seeking a more healthy lifestyle. He smiled at me and said that he would deal with these issues later. "Look", he said, "at least getting some exercise is a start".
The first steps in transitioning microarray- and quantitative reverse transcription-PCR (QRT-PCR)-based human-genome-wide RNA expression profiling from the current, primarily research, applications to the more exacting medical diagnostic and drug development arenas were made recently. The NIST organized a meeting in March 2003 (1) that focused singularly on establishing the types and properties of universal RNA reference materials to be used for expression-profiling assays. A summary of the proceedings and conclusions of the meeting is reported by Cronin et al. (2) in this issue. The principal conclusion of the workshop was that two types of RNA reference materials were needed: an Assay Process Control and an Array-Specific Hybridization reference material. The reported consensus of the meeting attendees was that such RNA reference materials would provide a measure of the accuracy, dynamic range, sensitivity, specificity, and reproducibility for the multiple types of currently available RNA expression technologies (arrays and QRT-PCR). Although acknowledging that there were several major challenges
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |